We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > puma

News List

Puma licences breast cancer therapy to Pierre Fabre in Europe pharmaceutical-technology
April 23, 2019
Puma licences breast cancer therapy to Pierre Fabre in Europe.
Puma to price new cancer med Nerlynx at a higher-than-expected $10K per month: report biospectrumasia
July 21, 2017
Shares of Puma Biotechnology have tripled since the start of the year to more than $95, as the Los Angeles company gets set to launch its debut drug, Nerlynx (neratinib) for HER2-positive breast cancer.
Puma gains as Roche breast cancer combo disappoints pharmaphorum
June 07, 2017
Few would have predicted that little biotech Puma would get the advantage over mighty Roche in the race to develop a new breast cancer drug.